International Clinical Trial: Use of Bone Marrow Stem Cells (MesenCell) for the Treatment of Patients With Chronic Graft-versus-host Disease

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07826676) titled 'Use of Bone Marrow Stem Cells (MesenCell) for the Treatment of Patients With Chronic Graft-versus-host Disease' on Sept. 1.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Pontificia Universidade Católica do Parana

Condition: Graft vs Host Disease Mesenchymal Stem Cell Transplantation

Intervention: Biological: Mesenchymal Stem Cell Infusion

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: October 2026

Target Sample Size: 20

Countries of Recruit...